-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Tq+fMU/YJghAXX8Po8/6vwh9d9qTquoNAEvlFB5pjyfBmRL8z/+ryoohq6DDcTKA F9sAo6HNfjPTT5CcJbhoyw== 0000891554-00-000094.txt : 20000202 0000891554-00-000094.hdr.sgml : 20000202 ACCESSION NUMBER: 0000891554-00-000094 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20000113 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PATIENT INFOSYSTEMS INC CENTRAL INDEX KEY: 0001017813 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 161476509 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: SEC FILE NUMBER: 005-50085 FILM NUMBER: 507104 BUSINESS ADDRESS: STREET 1: 46 PRINCE ST CITY: ROCHESTER STATE: NY ZIP: 14607 BUSINESS PHONE: 7162427200 MAIL ADDRESS: STREET 1: 46 PRINCE ST CITY: ROCHESTER STATE: NY ZIP: 14607 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: PROMED MANAGEMENT L L C CENTRAL INDEX KEY: 0001101088 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 043306892 STATE OF INCORPORATION: MA FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: C/O MUSKET RESEARCH ASSOCIATES INC STREET 2: 125 CAMBRIDGEPARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 SC 13G 1 SCHEDULE 13G ------------------------------ OMB APPROVAL ------------------------------ OMB Number Expires: Estimated average burden hours per response ....... 0.5 ------------------------------ SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. ) Patient Infosystems Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, $ .01 - -------------------------------------------------------------------------------- (Title of Class of Securities) 702915109 - -------------------------------------------------------------------------------- (CUSIP Number) January 5, 2000 - -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [_] Rule 13d-1(b) [X] Rule 13d-(c) [_] Rule 13d-1(d) - ---------- (1) The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). (SC13G-07/98) CUSIP No. 702915109 13G Page 2 of 8 Pages ________________________________________________________________________________ 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) ProMed Partners, L.P. ________________________________________________________________________________ 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X] (b) [_] ________________________________________________________________________________ 3. SEC USE ONLY ________________________________________________________________________________ 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware ________________________________________________________________________________ NUMBER OF 5. SOLE VOTING POWER SHARES 407,500 _________________________________________________________________ BENEFICIALLY 6. SHARED VOTING POWER OWNED BY _________________________________________________________________ EACH 7. SOLE DISPOSITIVE POWER REPORTING 407,500 _________________________________________________________________ PERSON 8. SHARED DISPOSITIVE POWER WITH ________________________________________________________________________________ 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 407,500 ________________________________________________________________________________ 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [_] ________________________________________________________________________________ 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.1% ________________________________________________________________________________ 12. TYPE OF REPORTING PERSON* PN ________________________________________________________________________________ *SEE INSTRUCTIONS BEFORE FILLING OUT! CUSIP No. 702915109 13G Page 3 of 8 Pages ________________________________________________________________________________ 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Barry Kurokawa ________________________________________________________________________________ 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X] (b) [_] ________________________________________________________________________________ 3. SEC USE ONLY ________________________________________________________________________________ 4. CITIZENSHIP OR PLACE OF ORGANIZATION United States ________________________________________________________________________________ NUMBER OF 5. SOLE VOTING POWER SHARES 18,000 _________________________________________________________________ BENEFICIALLY 6. SHARED VOTING POWER OWNED BY 425,500 _________________________________________________________________ EACH 7. SOLE DISPOSITIVE POWER REPORTING 18,000 _________________________________________________________________ PERSON 8. SHARED DISPOSITIVE POWER WITH 425,500 ________________________________________________________________________________ 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 425,500 (Reporting Person disclaims beneficial ownership of shares held by ProMed Partners, L.P., which represents the interests of other partners) ________________________________________________________________________________ 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [_] ________________________________________________________________________________ 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.3% ________________________________________________________________________________ 12. TYPE OF REPORTING PERSON* IN ________________________________________________________________________________ *SEE INSTRUCTIONS BEFORE FILLING OUT! CUSIP No. 702915109 13G Page 4 of 8 Pages ________________________________________________________________________________ Item 1(a). Name of Issuer: Patient Infosystems Inc. ________________________________________________________________________________ Item 1(b). Address of Issuer's Principal Executive Offices: 46 Prince Street, Rochester, NY 14607 ________________________________________________________________________________ Item 2(a). Name of Person Filing: ProMed Partners, L.P., and Barry Kurokawa ________________________________________________________________________________ Item 2(b). Address of Principal Business Office, or if None, Residence: 125 Cambridgepark Drive, Cambridge, MA 02140 ________________________________________________________________________________ Item 2(c). Citizenship: See pages 2 and 3 of this Schedule 13G ________________________________________________________________________________ Item 2(d). Title of Class of Securities: Common Stock, $.01 par value ________________________________________________________________________________ Item 2(e). CUSIP Number: 702915109 ________________________________________________________________________________ Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: (a) [_] Broker or dealer registered under Section 15 of the Exchange Act. (b) [_] Bank as defined in Section 3(a)(6) of the Exchange Act. (c) [_] Insurance company as defined in Section 3(a)(19) of the Exchange Act. (d) [_] Investment company registered under Section 8 of the Investment Company Act. (e) [_] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); (f) [_] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g) [_] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); (h) [_] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act; (i) [_] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act; (j) [_] Group, in accordance with Rule 13d-1(b)(1)(ii)(J). If this statement is filed pursuant to Rule 13d-1(c), check this box. [X] CUSIP No. 702915109 13G Page 5 of 8 Pages Item 4. Ownership. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: (b) Percent of class: (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote , see pages 2 and 3 (ii) Shared power to vote or to direct the vote , see pages 2 and 3 (iii) Sole power to dispose or to direct the disposition of , see pages 2 and 3 (iv) Shared power to dispose or to direct the disposition of see pages 2 and 3 ________________________________________________________________________________ Item 5. Ownership of Five Percent or Less of a Class. Not Applicable ________________________________________________________________________________ Item 6. Ownership of More Than Five Percent on Behalf of Another Person. Not Applicable ________________________________________________________________________________ Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. Not Applicable ________________________________________________________________________________ Item 8. Identification and Classification of Members of the Group. See Exhibit A ________________________________________________________________________________ Item 9. Notice of Dissolution of Group. Not Applicable ________________________________________________________________________________ Item 10. Certifications. (a) The following certification shall be included if the statement is filed pursuant to Rule 13d-1(b): "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect." (b) The following certification shall be included if the statement is filed pursuant to Rule 13d-1(c): "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect." CUSIP No. 702915109 Page 6 of 8 Pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. January 12, 2000 ---------------------------------------- (Date) /s/ Barry Kurokawa ---------------------------------------- (Signature) Barry Kurokawa, Member ---------------------------------------- (Name/Title) Note. Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7(b) for other parties for whom copies are to be sent. Attention. Intentional misstatements or omissions of fact constitute federal criminal violations (see 18 U.S.C. 1001). Page 7 of 8 pages Index to Exhibits Exhibit Page No. - ------- -------- Exhibit A--- Joint Filing Agreement, 8 dated January 12, 2000 Page 8 of 8 pages EXHIBIT A JOINT FILING AGREEMENT ProMed Partners, L.P. and Barry Kurokawa each hereby agree that the Schedule 13G to which this Exhibit is attached and any amendments thereto relating to the acquisition of shares of Common Stock of Patient Infosystems Inc. are filed jointly on behalf of each such person. Dated: January 12, 2000 PROMED PARTNERS, L.P. By: ProMed Asset Management, L.L.C. its General Partner By: /s/ Barry Kurokawa --------------------------- Name: Barry Kurokawa Title: Member -----END PRIVACY-ENHANCED MESSAGE-----